Aspirin may help breast and bladder cancer patients live longer

Embargoed until: Publicly released: 2021-01-16 03:00

International

CC-0

A US study of nearly 140,000 people looked at the effects of aspirin use on developing and surviving bladder, breast, esophageal, gastric, pancreatic, and uterine cancers, and found that while aspirin use was not associated with preventing cancers, it was associated with increased bladder and breast cancer survival. People with bladder and breast cancer who used aspirin lived longer than those with the diseases who did not, the researchers say.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo ends

Journal/
conference: JAMA Network Open

Research:Paper

Organisation/s: National Cancer Institute, USA

Funder: Cancer incidence data were provided by the Alabama Statewide Cancer Registry, Arizona Cancer Registry, Colorado Central Cancer Registry, District of Columbia Cancer Registry, Georgia Cancer Registry, Hawaii Cancer Registry, Cancer Data Registry of Idaho, Maryland Cancer Registry, Michigan Cancer Surveillance Program, Minnesota Cancer Surveillance System, Missouri Cancer Registry, Nevada Central Cancer Registry, Ohio Cancer Incidence Surveillance System, Pennsylvania Cancer Registry, Texas Cancer Registry, Utah Cancer Registry, Virginia Cancer Registry, and Wisconsin Cancer Reporting System. All are supported in part by funds from the US Centers for Disease Control and Prevention, National Program for Central Registries, local states, or by the National Cancer Institute Surveillance, Epidemiology, and End Results program. Data are available upon request.

Media Contact/s

Contact details are only visible to registered journalists.